SPPS Solvent Residues, TFA Salts and ICH Limits Explained

A GLP1 Forum Escrow guide for buyers. Educational and research reference only, not medical advice.

Why solvents can end up in a finished peptide

Most research peptides are built by solid phase peptide synthesis (SPPS), a process that relies heavily on organic solvents to couple, wash and cleave the growing chain (source). Some of those chemicals evaporate easily, notably trifluoroacetic acid (TFA), acetonitrile (ACN) and dichloromethane (DCM). Others, including dimethylformamide (DMF), dimethylacetamide (DCA) and N-methylpyrrolidone (NMP), are far less volatile (source). Purification and freeze-drying are supposed to strip them out. When those steps are cut short, traces can remain in the powder that reaches a buyer. Knowing how each solvent behaves, what the published limits are, and how residues are measured makes it easier to judge a certificate of analysis or decide what to test.

The usual SPPS solvents at a glance

Volatility is the main thing that predicts whether a solvent survives lyophilization. The lower the boiling point, the more readily it leaves under vacuum.

Notes on individual solvents

• TFA as free solvent. With a boiling point of 72°C, loose TFA tends to sublimate off during freeze-drying. A properly run lyophilization with several drying cycles should leave little or none behind.
• TFA as a counterion. The picture changes when TFA is bound to the peptide as its salt. If the manufacturer skipped the ion exchange that swaps TFA for sodium or acetate, or did not remove it to produce the base form, a meaningful fraction stays put through lyophilization (source: Janoshik). That bound TFA is what raises questions about pharmacokinetics and long-term effects.
• DCM and ACN. Both boil at low temperatures (40°C and 82°C), so like free TFA they are expected to leave readily during drying.
• DMF, DCA and NMP. At 153°C, 165°C and 202°C respectively, these are the solvents most likely to linger after lyophilization if a process is rushed, simply because they do not evaporate as easily.

Published limits and how to read them

Under International Council for Harmonisation (ICH) guidance, the common SPPS solvents fall into Class 2, the group with recognized potential for organ toxicity. For each one the guideline sets a Permitted Daily Exposure (PDE), the amount considered acceptable per day from a pharmaceutical product (source):

• ACN: 4.1 mg/day
• NMP: 5.3 mg/day
• DCM: 6.0 mg/day
• DMF: 8.8 mg/day
• DCA: 10.9 mg/day
• TFA: ≤0.1% of peptide raw product (source: the figure listed on COAs from US FDA-regulated 503A/503B compounding manufacturers)

A PDE is a mass per day, not a concentration, so the useful comparison is between the absolute amount of solvent present and the published figure. Peptide products are typically handled in milligram quantities. A batch would therefore need an unusually high residual concentration before the solvent mass it carries came anywhere near these limits. For a sense of scale, the ICH sets a PDE of 2 mg/day for acetaldehyde, a carcinogenic compound the body itself produces when metabolizing alcohol, while wine contains about 34 mg/L of it, or roughly 4.8 mg in a glass (source). None of this replaces a measured result; it only explains why the numbers on a COA should be read against the limit rather than in isolation.

The TFA question in more detail

In synthetic peptides, a trifluoroacetate counterion remains attached unless the manufacturer either exchanges it for a different salt or cleaves it away to leave the base peptide. Brand-name manufacturers and 503A/B compounding pharmacies apply a tighter TFA standard than the general solvent limits above, which reflects how seriously the counterion is taken in products intended for repeated, long-term exposure.

There are two reasons for that caution. First, TFA is an ultra-short-chain PFAS. Data on TFA specifically are still limited, but the wider PFAS family, often called “forever chemicals,” has been linked in numerous studies to disruption of the endocrine system, with associations reported for infertility and obesity (source). Second, the pharmaceutical industry itself describes TFA as “undesirable in peptides intended for preclinical and clinical studies” (source).

The practical takeaway for buyers is to check the salt form. Material supplied as tirzepatide sodium or tirzepatide acetate has been through the exchange step; material sold as a TFA salt has not. Where a listing or COA does not state the counterion, that is worth asking about before you buy, and a TFA result is worth requesting from the lab report.

Class 1 solvents: high hazard, low likelihood

A separate group of solvents carries much more serious toxicity concerns, although none of them is known to be part of the SPPS process. The ICH places these in Class 1. Rather than giving them a PDE, the guideline treats them as solvents to avoid in pharmaceutical manufacturing altogether and sets concentration ceilings in parts per million (ppm) that traces must stay below (source):

Deciding what to test

All five Class 1 solvents boil below 85°C, in the same range as TFA. That makes them very unlikely to survive freeze-drying, particularly when several drying cycles are run under vacuum, which lowers boiling points further. Add the fact that they are not known to be used in SPPS, and the case for routine Class 1 screening is weak. We do not generally recommend paying for it, given how low the probability of finding anything is. A better use of the testing budget:

• A TFA spot test as a proxy. TFA is normally present during manufacture and is about as volatile as the Class 1 group. If a sample comes back free of TFA, that is good evidence the lyophilization was thorough, and that other low-boiling residues such as benzene were removed along with it.

Lab methods that are available

For anyone who still wants residual solvents measured directly, two methods cover it:

• NMR F-19: fluorine-19 nuclear magnetic resonance spectroscopy picks up TFA through its fluorine atoms, which produce a peak near -73 to -76 ppm. It is the natural choice when TFA is the main concern (source).

• GC-FID: gas chromatography with flame ionization detection is the standard method for identifying and quantifying residual solvents in general, and it is the basis of the USP <467> procedure for residual solvent analysis (source).

Questions, corrections or feedback about this guide or the sources it cites are welcome; reach out to our support team.